421 related articles for article (PubMed ID: 28515341)
21. BET Protein Inhibition Prolongs Cardiac Transplant Survival via Enhanced Myocardial Autophagy.
Chen J; Miao X; Liu C; Liu B; Wu X; Kong D; Sun Q; Gong W
Transplantation; 2020 Nov; 104(11):2317-2326. PubMed ID: 32433238
[TBL] [Abstract][Full Text] [Related]
22. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
[TBL] [Abstract][Full Text] [Related]
23. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
24. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
25. STING activation in cardiomyocytes drives hypertrophy-associated heart failure via NF-κB-mediated inflammatory response.
Wang L; Zhang S; Liu H; Gao L; He L; Chen Y; Zhang J; Yang M; He C
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166997. PubMed ID: 38142758
[TBL] [Abstract][Full Text] [Related]
26. Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease.
Dukinfield M; Maniati E; Reynolds LE; Aubdool A; Baliga RS; D'Amico G; Maiques O; Wang J; Bedi KC; Margulies KB; Sanz-Moreno V; Hobbs A; Hodivala-Dilke K
J Pathol; 2019 Dec; 249(4):523-535. PubMed ID: 31424556
[TBL] [Abstract][Full Text] [Related]
27. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.
Tang L; Yao F; Wang H; Wang X; Shen J; Dai B; Wu H; Zhou D; Guo F; Wang J; Li T; Wang H; Gong T; Su J; Wang L; Liang P
J Mol Cell Cardiol; 2019 Jan; 126():143-154. PubMed ID: 30423318
[TBL] [Abstract][Full Text] [Related]
29. The function of miRNA in cardiac hypertrophy.
Wang J; Yang X
Cell Mol Life Sci; 2012 Nov; 69(21):3561-70. PubMed ID: 22926414
[TBL] [Abstract][Full Text] [Related]
30. Cardiomyocyte-Specific
Thirugnanam K; Cossette SM; Lu Q; Chowdhury SR; Harmann LM; Gupta A; Spearman AD; Sonin DL; Bordas M; Kumar SN; Pan AY; Simpson PM; Strande JL; Bishop E; Zou MH; Ramchandran R
J Am Heart Assoc; 2019 Nov; 8(22):e012792. PubMed ID: 31718444
[TBL] [Abstract][Full Text] [Related]
31. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury.
Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK
Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146
[TBL] [Abstract][Full Text] [Related]
32. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
33.
Higgins EM; Bos JM; Dotzler SM; John Kim CS; Ackerman MJ
Circ Genom Precis Med; 2019 Nov; 12(11):e002648. PubMed ID: 31638832
[TBL] [Abstract][Full Text] [Related]
34. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
35. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.
Ott CJ; Kopp N; Bird L; Paranal RM; Qi J; Bowman T; Rodig SJ; Kung AL; Bradner JE; Weinstock DM
Blood; 2012 Oct; 120(14):2843-52. PubMed ID: 22904298
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
37. Endothelial-derived extracellular vesicles from obese/hypertensive adults increase factors associated with hypertrophy and fibrosis in cardiomyocytes.
Fandl HK; Garcia VP; Treuth JW; Brewster LM; Greiner JJ; Davy KP; Stauffer BL; Desouza CA
Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H675-H685. PubMed ID: 36930654
[TBL] [Abstract][Full Text] [Related]
38. Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure.
Marques FZ; Prestes PR; Byars SG; Ritchie SC; Würtz P; Patel SK; Booth SA; Rana I; Minoda Y; Berzins SP; Curl CL; Bell JR; Wai B; Srivastava PM; Kangas AJ; Soininen P; Ruohonen S; Kähönen M; Lehtimäki T; Raitoharju E; Havulinna A; Perola M; Raitakari O; Salomaa V; Ala-Korpela M; Kettunen J; McGlynn M; Kelly J; Wlodek ME; Lewandowski PA; Delbridge LM; Burrell LM; Inouye M; Harrap SB; Charchar FJ
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28615213
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.
Asangani IA; Dommeti VL; Wang X; Malik R; Cieslik M; Yang R; Escara-Wilke J; Wilder-Romans K; Dhanireddy S; Engelke C; Iyer MK; Jing X; Wu YM; Cao X; Qin ZS; Wang S; Feng FY; Chinnaiyan AM
Nature; 2014 Jun; 510(7504):278-82. PubMed ID: 24759320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
